Literature DB >> 12624101

Inhibition of cell growth by conditional expression of kpm, a human homologue of Drosophila warts/lats tumor suppressor.

Yasuhiko Kamikubo1, Akifumi Takaori-Kondo, Takashi Uchiyama, Toshiyuki Hori.   

Abstract

kpm is a human serine/threonine kinase that is homologous to Drosophila tumor suppressor warts/lats and its mammalian homologue LATS1. In order to define the biological function of kpm, we generated stable transfectants of wild-type kpm (kpm-wt), a kinase-dead mutant of kpm (kpm-kd), and luciferase in HeLa Tet-Off cells under the tetracycline-responsive promoter. Western blot analysis showed that high levels of expression of kpm-wt as well as kpm-kd with an apparent mass of 150 kDa were induced after the removal of doxycycline. Induction of kpm-wt expression resulted in a marked decline in viable cell number measured by both trypan blue dye exclusion and MTT assay, whereas that of kpm-kd or luciferase had no effect. We then analyzed the cell cycle progression and apoptosis upon induction of kpm expression. 2-3 days after removal of doxycycline, cells underwent G(2)/M arrest, demonstrated by flow cytometric analysis of propidium iodide incorporation and MPM-2 reactivity. In vitro kinase assay showed that induction of kpm-wt led to down-regulation of kinase activity of the Cdc2-cyclin B complex, which was accompanied by an increase in the hyperphosphorylated form of Cdc2 and a change of phosphorylation status of Cdc25C. Furthermore, both DAPI staining and TUNEL assay showed that the proportion of apoptotic cells increased as kpm expression was induced. Taken together, these results indicate that kpm negatively regulates cell growth by inducing G(2)/M arrest and apoptotic cell death through its kinase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624101     DOI: 10.1074/jbc.M211974200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin.

Authors:  Hyun Hee Lee; Mai-Tram Vo; Hyo Jeong Kim; Unn Hwa Lee; Chae Won Kim; Hong Kyeung Kim; Myoung Seok Ko; Won Hyuck Lee; Seung Joo Cha; Young Joo Min; Dae Hwa Choi; Ho Seok Suh; Byung Ju Lee; Jeong Woo Park; Wha Ja Cho
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Mechanisms Underlying Mammalian Hybrid Sterility in Two Feline Interspecies Models.

Authors:  Brian W Davis; Christopher M Seabury; Wesley A Brashear; Gang Li; Melody Roelke-Parker; William J Murphy
Journal:  Mol Biol Evol       Date:  2015-05-25       Impact factor: 16.240

3.  LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.

Authors:  Chao Guo; Xintian Wang; Lufeng Liang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

Review 5.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

6.  MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.

Authors:  Rui-Qing Tian; Xing-Hua Wang; Li-Juan Hou; Wei-Hua Jia; Qian Yang; Yi-Xuan Li; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

7.  KIBRA regulates aurora kinase activity and is required for precise chromosome alignment during mitosis.

Authors:  Lin Zhang; Jyoti Iyer; Aparajita Chowdhury; Ming Ji; Ling Xiao; Shuping Yang; Yuanhong Chen; Ming-Ying Tsai; Jixin Dong
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

8.  Lats2 is a negative regulator of myocyte size in the heart.

Authors:  Yutaka Matsui; Noritsugu Nakano; Dan Shao; Shumin Gao; Wenting Luo; Chull Hong; Peiyong Zhai; Eric Holle; Xianzhong Yu; Norikazu Yabuta; Wufan Tao; Thomas Wagner; Hiroshi Nojima; Junichi Sadoshima
Journal:  Circ Res       Date:  2008-10-16       Impact factor: 17.367

9.  Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.

Authors:  Hidefumi Sasaki; Yu Hikosaka; Osamu Kawano; Motoki Yano; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

10.  The expression analysis of LATS2 gene in de novo AML patients.

Authors:  Milad Gholami; Reza Mirfakhraie; Abolfazl Movafagh; Hasan Jalaeekhoo; Ramezanali Kalahroodi; Davood Zare-Abdollahi; Shohreh Zare-Karizi
Journal:  Med Oncol       Date:  2014-04-18       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.